Showing 61 - 80 results of 82 for search '"respiratory disease"', query time: 0.08s Refine Results
  1. 61

    Photoredox-Catalyzed Decomposition of Nitric Oxide over Au-Enhanced Surface Plasmon Resonance ZnSn(OH)6 Microcubes by Minh-Thuan Pham, Truc Mai Thi Nguyen, Sheng-Jie You, Ya-Fen Wang

    Published 2023-02-01
    “…Therein, nitric oxide (NO) is the leading cause of the greenhouse effect, acid rain, and respiratory diseases. Therefore, discovering a low-cost, environmentally friendly, highly efficient photocatalysis technique to remove NO is necessary and urgent. …”
    Get full text
    Article
  2. 62

    Design and Analysis of thermosyphon Solar Water Heating System. by Kakuru, Stephen

    Published 2024
    “…In rural areas of Uganda, access to affordable hot water is a persistent challenge with communities often relying on firewood and charcoal for water heating which contributes to deforestation, air pollution, and health hazards hence respiratory diseases like asthma, lung cancer, TB, and allergic disease, climate changes and global warming. …”
    Get full text
    Thesis
  3. 63
  4. 64

    Associations between Ozone and Emphysema: A Systematic Review and Meta-analysis by Amja Manullang, Yueh-Lun Lee, Vincent Laiman, Jer-Hwa Chang, Hsiao-Chi Chuang

    Published 2022-05-01
    “…Increasing O3 concentrations may have an impact on and exacerbate human health conditions such as emphysema and respiratory diseases. Air quality and climate change should be concerns for future environmental policies and protection measures.…”
    Get full text
    Article
  5. 65

    Martini compatible coarse-grained model of polyethylenimine for pulmonary gene delivery by Graham Lunt, Niloofar Hashemi, Subhamoy Mahajan, Tian Tang

    Published 2025-02-01
    “…Abstract Pulmonary gene delivery has demonstrated high specificity for respiratory diseases, offering great control on dosage of therapeutics and side effects. …”
    Get full text
    Article
  6. 66
  7. 67
  8. 68

    Isolation, genetic, and biological characterization of human adenovirus type 55 positive isolates from Wuhan, China by Jing Xie, Yan Wang, Huan Li, Bingxiu Tan, Zhengying Yu, Lizhong Li, Wei Zhang, Hongbin Song, Leili Jia

    Published 2025-02-01
    “…Abstract Background Human adenovirus (HAdV) infection causes acute respiratory diseases in immunocompetent individuals worldwide. …”
    Get full text
    Article
  9. 69

    Drug Concentrations in the Air and their Influencing Factors in a Pediatric Intensive Care Unit by Hui-Yun Tseng, Yi-Ting Tsai, Ying-Shiuan Su, Po-Pei Peng, Gwo-Hwa Wan

    Published 2024-02-01
    “…Abstract Aerosolized drug therapy is a common approach in treating respiratory diseases in clinical practice. This study aimed to assess air quality in the pediatric intensive care unit (PICU) of the medical center and investigate variations in drug concentration relative to the patient’s position during aerosolized drug treatment. …”
    Get full text
    Article
  10. 70

    Identification of serum tRNA-derived small RNAs biosignature for diagnosis of tuberculosis by Zikun Huang, Qing Luo, Cuifen Xiong, Haiyan Zhu, Chao Yu, Jianqing Xu, Yiping Peng, Junming Li, Aiping Le

    Published 2025-12-01
    “…The objective of the present study was to evaluate the performance of the serum tsRNAs biosignature to distinguish between active TB, healthy controls, latent TB infection, and other respiratory diseases. The differential expression profiles of tsRNAs in serum from active TB patients and healthy controls were analyzed by high-throughput sequencing. …”
    Get full text
    Article
  11. 71

    Dendriform pulmonary ossification in military combat veterans: A case series by Jeremy T. Hua, Carlyne D. Cool, Tami J. Bang, Silpa D. Krefft, Richard C. Kraus, Cecile S. Rose

    Published 2025-01-01
    “…We queried research databases of military personnel evaluated for deployment-related respiratory diseases at two occupational pulmonary medicine clinics (Colorado, USA) for diagnoses of DPO, and summarized demographics, Gulf War military deployment history, medical history, and pulmonary function testing. …”
    Get full text
    Article
  12. 72

    Analysis of Air Quality and Health Co-Benefits under Low Carbon Pathway in Taiwan by Hsin-Chih Lai, Shih-Ming Chung, Li-Ling Li, Wen-Yinn Lin, Min-Chuan Hsiao

    Published 2024-05-01
    “…In the short term, it is projected that there may be a decrease of 45 patients hospitalized due to respiratory diseases and 53 patients hospitalized due to cardiovascular diseases. …”
    Get full text
    Article
  13. 73
  14. 74

    Linking PM Pollution to the Respiratory Health of Children: A Cross-sectional Study from Ahmedabad City in Western India by Khyati M. Kakkad, Chirantap Oza, Priya Dutta, Varsha Chorsiya, Prashant Rajput

    Published 2022-04-01
    “…Children living in developing countries suffer a double burden of respiratory diseases. The present study aims to find out the risk of short-term exposure to PM2.5 on respiratory admissions of children under 6 from Ahmedabad city in western India. …”
    Get full text
    Article
  15. 75

    Unlocking the link: predicting cardiovascular disease risk with a focus on airflow obstruction using machine learning by Xiyu Cao, Jianli Ma, Xiaoyi He, Yufei Liu, Yang Yang, Yaqi Wang, Chuantao Zhang

    Published 2025-02-01
    “…Abstract Background Respiratory diseases and Cardiovascular Diseases (CVD) often coexist, with airflow obstruction (AO) severity closely linked to CVD incidence and mortality. …”
    Get full text
    Article
  16. 76
  17. 77
  18. 78

    Impact of pulmonary yoga module on lung capacity of COVID-19 adult survivors by Adarsh Tomar, Sudhanshu Verma

    Published 2024-07-01
    “…Numerous complications can occur if lungs are compressed; cardiovascular and respiratory diseases are most common in such circumstances. …”
    Get full text
    Article
  19. 79

    Association of Serum Irisin With Severity and Prognosis in Patients With Coronavirus Disease 2019: A Prospective Cohort Study by Zhang X, Wang W, Li Y, Liu X, Zhang L, Cheng Z, Liu M, Wang Y, Fu L, Yang J

    Published 2025-02-01
    “…Xinli Zhang,1,2,* Wennan Wang,1,3,* Ye Li,2 Xiaoning Liu,2 Liangzhu Zhang,2 Zhenyu Cheng,1,4 Mingyan Liu,1,4 Yu Wang,1,4 Lin Fu,1,4 Jin Yang1,4,5 1Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, People’s Republic of China; 2The First Department of Tuberculosis, Anhui Chest Hospital, Hefei, Anhui Province, People’s Republic of China; 3The Fifth Department of Tuberculosis, Anhui Chest Hospital, Hefei, Anhui Province, People’s Republic of China; 4Institute of Respiratory Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, People’s Republic of China; 5Information Management Center, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, People’s Republic of China*These authors contributed equally to this workCorrespondence: Lin Fu; Jin Yang, Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, People’s Republic of China, Email fulindev@126.com; yangqj1015@foxmail.comBackground: Irisin is the cleaved form of fibronectin type III domain-containing protein 5 (FNDC5), which can confer antioxidant and anti-inflammatory effects. …”
    Get full text
    Article
  20. 80

    Potentially inappropriate prescribing in hospitalised children: a retrospective, cross-sectional study at a tertiary children’s hospital in China by Linan Zeng, Lingli Zhang, Dan Yu, Huiqing Wang, Liang Huang, Siyu Li, Guo Cheng, Zhi-Jun Jia

    Published 2023-05-01
    “…‘Inhaled corticosteroids for children with respiratory infections but without chronic respiratory diseases’ was the most frequent PIP. Logistic regression results showed that PIP was more likely to occur in male patients (OR 1.128, 95% CI 1.059 to 1.202) and younger patients (<2 years old; OR 1.974; 95% CI 1.739 to 2.241), and in those with more comorbidities (≥11 types; OR 4.181; 95% CI 3.671 to 4.761), concomitant drugs (≥11 types; OR 22.250; 95% CI 14.468 to 34.223) or longer hospital stay (≥30 days; OR 8.130; 95% CI 6.727 to 9.827).Conclusions Medications for long-term hospitalised young children with multiple comorbidities should be minimised and optimised, to avoid PIP, reduce adverse drug reactions and ensure children’s medication safety. …”
    Get full text
    Article